Chakraborty K, Kizhakkekalam V K, Joy M
Marine Bioprospecting Section of Marine Biotechnology Division, Central Marine Fisheries Research Institute, Ernakulam North, P.B. No. 1603, Cochin, India.
Faculty of Marine Sciences, Cochin University of Science and Technology, Kerala State, Lakeside Campus, Cochin, India.
J Appl Microbiol. 2021 May;130(5):1552-1570. doi: 10.1111/jam.14875. Epub 2020 Oct 27.
Biotechnological and chemical characterization of previously undescribed homologous siderophore-type macrocyclic polyketides from heterotrophic Shewanella algae Microbial Type Culture Collection (MTCC) 12715 affiliated with Rhodophycean macroalga Hypnea valentiae of marine origin, with significant anti-infective potential against drug-resistant pathogens.
The heterotrophic bacterial strain in symbiotic association with intertidal macroalga H. valentiae was isolated to homogeneity in a culture-dependent method and screened for bioactivities by spot-over-lawn assay. The bacterial organic extract was purified and characterized by extensive chromatographic and spectroscopic methods, respectively, and was assessed for antibacterial activities with disc diffusion and microtube dilution methods. The macrocyclic polyketide compounds exhibited wide-spectrum of anti-infective potential against clinically significant vancomycin-resistant Enterococcus faecalis (VREfs), methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa and Klebsiella pneumonia with minimum inhibitory concentration of about 1-3 µg ml , insomuch as the antibiotics chloramphenicol and ampicillin were active at ≥6·25 µg ml . The studied compounds unveiled Fe chelating activity, which designated that their prospective anti-infective activities against the pathogens could be due to their siderophore mechanism of action. In support of that, the bacterium exhibited siderophore production on bioassay involving the cast upon culture agar plate, and the presence of siderophore biosynthetic gene (≈1000 bp) (MF 981936) further corroborated the inference. In silico molecular modelling with penicillin-binding protein (PBP2a) coded by mecA genes of MRSA (docking score -11·68 to -12·69 kcal mol ) verified their in vitro antibacterial activities. Putative biosynthetic pathway of macrocyclic polyketides through stepwise decarboxylative condensation initiated by malonate-acyl carrier protein further validated their structural and molecular attributes.
The studied siderophore-type macrocyclic polyketides from S. algae MTCC 12715 with significant anti-infective potential could be considered as promising candidates for pharmaceutical and biotechnological applications, especially against emerging multidrug-resistant pathogens.
This study exhibited the heterotrophic bacteria in association with intertidal macroalga as propitious biological resources to biosynthesize novel antibacterial agents.
对来自与海洋红藻Hypnea valentiae相关的异养海藻希瓦氏菌(Shewanella algae)微生物模式培养物保藏中心(MTCC)12715中以前未描述的同源铁载体型大环聚酮化合物进行生物技术和化学表征,该化合物对耐药病原体具有显著的抗感染潜力。
采用依赖培养的方法将与潮间带大型海藻H. valentiae共生的异养细菌菌株分离纯化,并通过点种平板法筛选其生物活性。分别采用广泛的色谱和光谱方法对细菌有机提取物进行纯化和表征,并采用纸片扩散法和微量管稀释法评估其抗菌活性。大环聚酮化合物对临床上重要的耐万古霉素粪肠球菌(VREfs)、耐甲氧西林金黄色葡萄球菌(MRSA)、铜绿假单胞菌和肺炎克雷伯菌表现出广谱的抗感染潜力,最低抑菌浓度约为1 - 3 μg/ml,而抗生素氯霉素和氨苄西林在≥6.25 μg/ml时才有活性。所研究的化合物具有铁螯合活性,这表明它们对病原体的潜在抗感染活性可能归因于其铁载体作用机制。支持这一点的是,该细菌在涉及在培养琼脂平板上接种的生物测定中表现出铁载体产生,并且铁载体生物合成基因(≈1000 bp)(MF 981936)的存在进一步证实了这一推断。用MRSA的mecA基因编码的青霉素结合蛋白(PBP2a)进行的计算机分子模拟(对接分数为 - 11.68至 - 12.69 kcal/mol)验证了它们的体外抗菌活性。通过丙二酸 - 酰基载体蛋白引发的逐步脱羧缩合形成大环聚酮化合物的推定生物合成途径进一步验证了它们的结构和分子特性。
所研究的来自海藻希瓦氏菌MTCC 12715的具有显著抗感染潜力的铁载体型大环聚酮化合物可被视为药物和生物技术应用的有前途的候选物,特别是针对新出现的多重耐药病原体。
本研究表明与潮间带大型海藻相关的异养细菌是生物合成新型抗菌剂的有利生物资源。